Der Internist

, Volume 47, Issue 2, pp 141–149

Folgeerkrankungen und Komplikationen der Adipositas

Schwerpunkt: Adipositas und Innere Medizin

Zusammenfassung

Übergewicht und Adipositas führen zu einer Vielzahl von Komplikationen und Begleiterkrankungen, die nahezu alle Organsysteme betreffen. Die Adipositas ist mit allen Komponenten des metabolischen Syndroms assoziiert und ein wesentlicher Bestandteil in der Pathogenese des Typ-2-Diabetes mellitus. Die Adipositas selbst, aber auch viele Komorbiditäten sind für das hohe kardiovaskuläre Risiko verantwortlich. Dadurch und durch andere Komplikationen wie die erhöhte Inzidenz von Tumorerkrankungen ist die Übersterblichkeit von Übergewichtigen zu erklären. Aber auch weniger bekannte Komplikationen wie Polyzystisches-Ovar-Syndrom und Schlaf-Apnoe-Syndrom sind häufig bei Übergewichtigen zu finden. Bei der Betreuung von Menschen mit Adipositas steht nicht nur die Gewichtsreduktion, sondern auch ein Screening auf Begleit- und Folgeerkrankungen im Vordergrund.

Schlüsselwörter

Adipositas Übergewicht Schlaf-Apnoe-Syndrom Metabolisches Syndrom 

Co-morbidities and complications of adiposis

Abstract

Overweight and obesity are associated with a high number of complications and co-morbidities. Obesity can affect almost all tissues and organs of the body. Obesity is associated with the components of the metabolic syndrome and is the leading cause of type 2 diabetes. Either obesity itself or co-morbidities of obesity are responsible for the increased cardiovascular risk. The increased overall mortality risk is due to cardiovascular and other complications like the higher prevalence and incidence of malignant tumors. Other complications of obesity like the polycystic ovary syndrome or the obstructive sleep apnea syndrome are relatively unknown but important and frequent. Medical care of people with obesity should focus not only on weight loss but also on complications and co-morbidities.

Keywords

Adiposis Obesity Obstructive sleep apnea syndrome Metabolic syndrome 

Literatur

  1. 1.
    Ascherio A, Hennekens C, Willett WC et al. (1996) Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27: 1065–1072PubMedGoogle Scholar
  2. 2.
    Bosello O, Zamboni M (2000) Visceral obesity and metabolic syndrome. Obes Rev 1: 47–56CrossRefPubMedGoogle Scholar
  3. 3.
    Busetto L, Enzi G, Inelmen EM, Costa G, Negrin V, Sergi G, Vianello A (2005) Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. Chest 128: 618–623CrossRefPubMedGoogle Scholar
  4. 4.
    Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341: 1097–1105PubMedGoogle Scholar
  5. 5.
    Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17: 961–969PubMedGoogle Scholar
  6. 6.
    Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, MacLean LD (2004) Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240: 416–423PubMedGoogle Scholar
  7. 7.
    Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122: 481–486PubMedGoogle Scholar
  8. 8.
    Dal Maso L, Augustin LS, Karalis A et al. (2004) Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 89: 1160–1163CrossRefPubMedGoogle Scholar
  9. 9.
    Despres JP (1994) Dyslipidaemia and obesity. Baillieres Clin Endocrinol Metab 8: 629–660CrossRefPubMedGoogle Scholar
  10. 10.
    Despres JP, Lemieux I, Prud’homme D (2001) Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 322: 716–720PubMedGoogle Scholar
  11. 11.
    Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365: 1415–1428CrossRefPubMedGoogle Scholar
  12. 12.
    Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352: 1223–1236CrossRefPubMedGoogle Scholar
  13. 13.
    Emons G, Geisthövel F, Hinney B, Partsch CJ, Sippell W, Wuttke WH (2003) Gynäkologische Endokrinologie. In: Deutsche Gesellschaft für Endokrinologie (Hrsg) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart, S 241–276Google Scholar
  14. 14.
    Federation ID (2005) The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf
  15. 15.
    Formiguera X, Canton A (2004) Obesity: epidemiology and clinical aspects. Best Pract Res Clin Gastroenterol 18: 1125–1146CrossRefPubMedGoogle Scholar
  16. 16.
    Friedrich MJ (2003) Researchers explore obesity-cancer link. JAMA 290: 2790–2791CrossRefPubMedGoogle Scholar
  17. 17.
    Giacchetti G, Faloia E, Mariniello B et al. (2002) Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15: 381–388CrossRefPubMedGoogle Scholar
  18. 18.
    Gibson GJ (2004) Obstructive sleep apnoea syndrome: underestimated and undertreated. Br Med Bull 72: 49–65CrossRefPubMedGoogle Scholar
  19. 19.
    Gopal M, Duntley S, Uhles M, Attarian H (2002) The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 3: 401–404CrossRefPubMedGoogle Scholar
  20. 20.
    Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF (2003) Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. Ann Intern Med 138: 383–389PubMedGoogle Scholar
  21. 21.
    Griffin ME, Marcucci MJ, Cline GW et al. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48: 1270–1274PubMedGoogle Scholar
  22. 22.
    Hotamisligil GS (1999) The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intern Med 245: 621–625CrossRefPubMedGoogle Scholar
  23. 23.
    Juhan-Vague I, Alessi MC, Mavri A, Morange PE (2003) Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 1: 1575–1579CrossRefPubMedGoogle Scholar
  24. 24.
    Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 48: 1684–1699CrossRefPubMedGoogle Scholar
  25. 25.
    Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663–1672PubMedGoogle Scholar
  26. 26.
    Koenig SM (2001) Pulmonary complications of obesity. Am J Med Sci 321: 249–279CrossRefPubMedGoogle Scholar
  27. 27.
    Lakka HM, Lakka TA, Tuomilehto J, Salonen JT (2002) Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 23: 706–713CrossRefPubMedGoogle Scholar
  28. 28.
    Lauer MS, Anderson KM, Kannel WB, Levy D (1991) The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 266: 231–236CrossRefPubMedGoogle Scholar
  29. 29.
    Lean ME, Han TS, Morrison CE (1995) Waist circumference as a measure for indicating need for weight management. BMJ 311: 158–161PubMedGoogle Scholar
  30. 30.
    Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, Williams GR (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110: 1245–1250CrossRefPubMedGoogle Scholar
  31. 31.
    Manson JE, Willett WC, Stampfer MJ et al. (1995) Body weight and mortality among women. N Engl J Med 333: 677–685CrossRefPubMedGoogle Scholar
  32. 32.
    Mortimore IL, Marshall I, Wraith PK, Sellar RJ, Douglas NJ (1998) Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med 157: 280–283PubMedGoogle Scholar
  33. 33.
    Okosun IS, Chandra KM, Choi S, Christman J, Dever GE, Prewitt TE (2001) Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res 9: 1–9PubMedGoogle Scholar
  34. 34.
    Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L (2003) Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138: 24–32PubMedGoogle Scholar
  35. 35.
    Pi-Sunyer FX (1996) A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther 18: 1006–1035CrossRefPubMedGoogle Scholar
  36. 36.
    Redon J (2001) Hypertension in obesity. Nutr Metab Cardiovasc Dis 11: 344–353PubMedGoogle Scholar
  37. 37.
    Ronnemaa T, Koskenvuo M, Marniemi J et al. (1997) Glucose metabolism in identical twins discordant for obesity. The critical role of visceral fat. J Clin Endocrinol Metab 82: 383–387CrossRefPubMedGoogle Scholar
  38. 38.
    Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41–47CrossRefPubMedGoogle Scholar
  39. 39.
    Schaub B, von Mutius E (2005) Obesity and asthma, what are the links? Curr Opin Allergy Clin Immunol 5: 185–193PubMedGoogle Scholar
  40. 40.
    Sjostrom L, Lindroos AK, Peltonen M et al. (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: 2683–2693CrossRefPubMedGoogle Scholar
  41. 41.
    Sonnenberg GE, Krakower GR, Kissebah AH (2004) A novel pathway to the manifestations of metabolic syndrome. Obes Res 12: 180–186PubMedGoogle Scholar
  42. 42.
    Sorensen TI (2003) Weight loss causes increased mortality: pros. Obes Rev 4: 3–7CrossRefPubMedGoogle Scholar
  43. 43.
    Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL (1998) The effect of age on the association between body-mass index and mortality. N Engl J Med 338: 1–7CrossRefPubMedGoogle Scholar
  44. 44.
    Stradling JR, Davies RJ (2004) Sleep. 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history. Thorax 59: 73–78CrossRefPubMedGoogle Scholar
  45. 45.
    Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, Paik MC (2003) Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 34: 1586–1592CrossRefPubMedGoogle Scholar
  46. 46.
    van den Brandt PA, Spiegelman D, Yaun SS et al. (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152: 514–527CrossRefPubMedGoogle Scholar
  47. 47.
    Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP (2001) Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86: 517–520CrossRefPubMedGoogle Scholar
  48. 48.
    WHO (2000) Obesity: preventing and managing the global epidemic. WHO Technical Report Series 894Google Scholar
  49. 49.
    Yamauchi T, Kamon J, Waki H et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941–946CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag 2005

Authors and Affiliations

  1. 1.Medizinische Klinik InnenstadtKlinikum der Universität München
  2. 2.DiabeteszentrumMedizinische Klinik InnenstadtMünchen

Personalised recommendations